Cargando…
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission
Outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) for adult acute lymphoblastic leukemia (ALL) have improved over time. Studies have shown that total body irradiation (TBI) is the preferable type of myeloablative conditioning (MAC). However, outcomes based on central nervous syste...
Autores principales: | Kharfan-Dabaja, Mohamed A., Labopin, Myriam, Bazarbachi, Ali, Salmenniemi, Urpu, Mielke, Stephan, Chevallier, Patrice, Thérèse Rubio, Marie, Balsat, Marie, Pioltelli, Pietro, Menard, Anne-Lise, Socié, Gerard, Huynh, Anne, Schaap, Nicolaas, Bermúdez Rodríguez, Arancha, Cornelissen, Jan J., Yakoub-Agha, Ibrahim, Aljurf, Mahmoud, Giebel, Sebastian, Brissot, Eolia, Peric, Zina, Nagler, Arnon, Mohty, Mohamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561382/ https://www.ncbi.nlm.nih.gov/pubmed/36258923 http://dx.doi.org/10.1097/HS9.0000000000000788 |
Ejemplares similares
-
Haploidentical Versus Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
por: Nagler, Arnon, et al.
Publicado: (2022) -
Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease
por: Mohty, Razan, et al.
Publicado: (2022) -
New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia
por: Mohty, Razan, et al.
Publicado: (2023) -
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
por: Pavlů, Jiří, et al.
Publicado: (2019) -
Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT
por: Hirschbühl, Klaus, et al.
Publicado: (2023)